全文获取类型
收费全文 | 181489篇 |
免费 | 35033篇 |
国内免费 | 2609篇 |
专业分类
耳鼻咽喉 | 5476篇 |
儿科学 | 6460篇 |
妇产科学 | 3148篇 |
基础医学 | 7020篇 |
口腔科学 | 2172篇 |
临床医学 | 29656篇 |
内科学 | 53849篇 |
皮肤病学 | 7974篇 |
神经病学 | 17184篇 |
特种医学 | 7365篇 |
外科学 | 45761篇 |
综合类 | 1144篇 |
现状与发展 | 72篇 |
一般理论 | 17篇 |
预防医学 | 9196篇 |
眼科学 | 4744篇 |
药学 | 3408篇 |
1篇 | |
中国医学 | 201篇 |
肿瘤学 | 14283篇 |
出版年
2024年 | 521篇 |
2023年 | 4957篇 |
2022年 | 1476篇 |
2021年 | 3840篇 |
2020年 | 6491篇 |
2019年 | 2885篇 |
2018年 | 8198篇 |
2017年 | 7917篇 |
2016年 | 9070篇 |
2015年 | 9184篇 |
2014年 | 16527篇 |
2013年 | 16833篇 |
2012年 | 7491篇 |
2011年 | 7623篇 |
2010年 | 11590篇 |
2009年 | 15255篇 |
2008年 | 7589篇 |
2007年 | 5815篇 |
2006年 | 8157篇 |
2005年 | 5367篇 |
2004年 | 4631篇 |
2003年 | 3408篇 |
2002年 | 3358篇 |
2001年 | 4969篇 |
2000年 | 4080篇 |
1999年 | 4128篇 |
1998年 | 3950篇 |
1997年 | 3693篇 |
1996年 | 3570篇 |
1995年 | 3418篇 |
1994年 | 2129篇 |
1993年 | 1724篇 |
1992年 | 1904篇 |
1991年 | 1907篇 |
1990年 | 1507篇 |
1989年 | 1601篇 |
1988年 | 1396篇 |
1987年 | 1209篇 |
1986年 | 1230篇 |
1985年 | 1055篇 |
1984年 | 790篇 |
1983年 | 744篇 |
1982年 | 661篇 |
1981年 | 510篇 |
1980年 | 479篇 |
1979年 | 487篇 |
1978年 | 435篇 |
1977年 | 512篇 |
1975年 | 343篇 |
1972年 | 372篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
Tien‐Yao Tsai Iat‐Lon Leong Ka‐Shun Cheng Lian‐Ru Shiao Tzu‐Hui Su Kar‐Lok Wong Paul Chan Yuk‐Man Leung 《Fundamental & clinical pharmacology》2019,33(1):52-62
A pathological feature in atherosclerosis is the dysfunction and death of vascular endothelial cells (EC). Oxidized low‐density lipoprotein (LDL), known to accumulate in the atherosclerotic arterial walls, impairs endothelium‐dependent relaxation and causes EC apoptosis. A major bioactive ingredient of the oxidized LDL is lysophosphatidylcholine (LPC), which at higher concentrations causes apoptosis and necrosis in various EC. There is hitherto no report on LPC‐induced cytotoxicity in brain EC. In this work, we found that LPC caused cytosolic Ca2+ overload, mitochondrial membrane potential decrease, p38 activation, caspase 3 activation and eventually apoptotic death in mouse cerebral bEND.3 EC. In contrast to reported reactive oxygen species (ROS) generation by LPC in other EC, LPC did not trigger ROS formation in bEND.3 cells. Pharmacological inhibition of p38 alleviated LPC‐inflicted cell death. We examined whether heparin could be cytoprotective: although it could not suppress LPC‐triggered Ca2+ signal, p38 activation and mitochondrial membrane potential drop, it did suppress LPC‐induced caspase 3 activation and alleviate LPC‐inflicted cytotoxicity. Our data suggest LPC apoptotic death mechanisms in bEND.3 might involve mitochondrial membrane potential decrease and p38 activation. Heparin is protective against LPC cytotoxicity and might intervene steps between mitochondrial membrane potential drop/p38 activation and caspase 3 activation. 相似文献
52.
53.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献
54.
55.
56.
57.
58.
Matrine,oxymatrine, and compound Kushen injection from the roots of Sophora flavescens: an overview of their anticancer activities 下载免费PDF全文
In the present review, we updated current information on the chemistry, contents, and anticancer properties of matrine (MT), oxymatrine (OMT), and compound Kushen injection (CKI). The anticancer properties were focused on lung, breast, and liver cancer cells because they are most susceptible. Sources of information were from Google, Google Scholar, PubMed, PubMed Central, Science Direct, PubChem, J-Stage, Directory of Open Access Journals (DOAJ), and China National Knowledge Infrastructure (CNKI). Reference was also made on botanical websites, such as Flora of China and World Flora Online. MT and OMT are dominant quinolizidine alkaloids from the roots of Sophora flavescens (Kushen) of the family Fabaceae. Against lung, breast, and liver cancer cells, MT and OMT inhibit cell proliferation; induce cell cycle arrest, apoptosis, and autophagy; restrict angiogenesis; and inhibit cell metastasis, invasion, and migration. The processes involve various molecular targets and signaling pathways. CKI is a traditional Chinese medicine (TCM) composed of root extracts of S. flavescens and Smilax glabra (Baituling) of the family Smilacaceae. With MT and OMT as major components, CKI has been approved for the treatment of cancer in China more than 20 years ago. In recent years, systematic reviews and meta-analysis have been undertaken to evaluate the anticancer effects of CKI. When CKI is used alone and in combination with chemotherapy of western medicine, there is much to be learned concerning their interactions besides their individual and integrated efficacy. Some perspectives of MT, OMT, and CKI are discussed, and their suggestions for future research are provided. 相似文献
59.